Table 1. Definitions of Correct Practice & Adequate Knowledge.
Correct Malaria Diagnosis | |
Utilization of microscopy or rapid diagnostic test | |
Clinical diagnosis when diagnostic test unavailable | |
Correct Pregnancy Assessment | |
Inquired about pregnancy and/ or offered pregnancy test | |
Inquired about LMP, gestational age, or measured fundal height or palpated | |
Correct Treatment & Dosage | |
Acceptable Knowledge Answers | Acceptable Prescriptions in Practice |
Non-pregnant | Non-pregnant |
1st-line: Artemether-lumefantrine | Artemether-lumefantrine |
2nd-line: DHA-piperaquine | DHA-piperaquine |
Quinine | |
1st Trimester | 1st Trimester |
Quinine | Quinine |
2nd/3rd Trimester | 2nd/3rd Trimester |
Quinine | Quinine |
Artemether-lumefantrine | Artemether-lumefantrine |
DHA-piperaquine | |
Treatment regimens: | |
Artemether-lumefantrine tablets (20/120 mg): 4 tablets, 2 times daily for 3 days (4x2x3) | |
DHA-piperaquine tablets (40/320 mg): 3 or 4 tablets, once daily for 3 days (3x1x3) or (4x1x3) | |
Quinine: 2 tablets of 300 mg, 3 times daily for 7 days (2x3x7)* |
Acronyms: LMP, date of last menstruation period; DHA, dihydroartemisinin,
*Differs from standard adult dosing regimen of 5 full days